Search results for: 'medgen and acquisition texas and agreements in pharma'
- Related search terms
- Acquisition Terms and Agreements in Pharma
- acquisition texas and agreements in pharma
- medgen and acquisition deal of 2017
- medgen and acquisition deal and alliance of 2015
- medgen and acquisition deaf and alliance of 221b
-
Current Agreements 12 Month AccessNovember 2024$5,995.00Powerful Intelligence for Dealmakers...
Leading deals and alliances database for the life sciences sector
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024September 2024$3,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Hematology Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More
